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Abstract
The blood flow through the major vessels holds great diagnostic potential for the identifica-
tion of cardiovascular complications and is therefore routinely assessed with current diag-
nostic modalities. Heart valves are subject to high hydrodynamic loads which render them
prone to premature degradation. Failing native aortic valves are routinely replaced with bio-
prosthetic heart valves. This type of prosthesis is limited by a durability that is often less than
the patient’s life expectancy. Frequent assessment of valvular function can therefore help
to ensure good long-term outcomes and to plan reinterventions. In this article, we describe
how unsupervised novelty detection algorithms can be used to automate the interpretation
of blood flow data to improve outcomes through early detection of adverse cardiovascular
events without requiring repeated check-ups in a clinical environment. The proposed
method was tested in an in-vitro flow loop which allowed simulating a failing aortic valve in a
laboratory setting. Aortic regurgitation of increasing severity was deliberately introduced
with tube-shaped inserts, preventing complete valve closure during diastole. Blood flow
recordings from a flow meter at the location of the ascending aorta were analyzed with the
algorithms introduced in this article and a diagnostic index was defined that reflects the
severity of valvular degradation. The results indicate that the proposed methodology offers
a high sensitivity towards pathological changes of valvular function and that it is capable of
automatically identifying valvular degradation. Such methods may be a step towards com-
puter-assisted diagnostics and telemedicine that provide the clinician with novel tools to
improve patient care.
Introduction
Heart valve disease is an increasingly common pathology of the cardiovascular system and
more than 800,000 patients annually are expected to require heart valve replacement by 2050
[1]. Aortic valve (AV) replacement with a bioprosthetic heart valve (BHV) is a common ther-
apy for a failing native AV. Despite good short- and mid-term outcomes, long-term results are
limited by insufficient BHV durability [2]. The durability of BHVs depends on many factors,
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such as age and comorbidities [3, 4], but the exact causality of BHV failure is still not fully
understood preventing accurate prediction of BHV durability. This renders the management
of these valves difficult and creates a need for close monitoring of valvular function. Current
diagnostic modalities include Doppler echocardiography or flow-MRI. These technologies rely
on the measurement of blood flow, which is an important indicator of cardiovascular health.
Valvular malfunctions show blood flow characteristics that deviate from those of the healthy
AV, and these characteristic blood flow patterns are therefore used for the diagnosis of heart
valve degradation. The current diagnostic procedures are labor- and cost intensive, limiting
the frequency at which medical exams can be performed. Automation of data acquisition (e.g.
through flow sensing implants) and diagnostic tasks has the potential to improve outcomes of
AV replacement therapies by early detection of adverse cardiac events while reducing costs
and minimizing hospital time. Implantable medical sensors and telemedicine continue to
increase in popularity because of their potential to reduce the cost of healthcare and to enable
remote patient management in areas with limited access to medical care [5–7]. These technol-
ogies allow for continuous and long-term disease monitoring that is not limited by access to
clinical personnel. The rapid development of data acquisition systems that utilize implantable
sensors creates a need for automated analysis of medical data that is scalable to a large patient
base. Artificial intelligence and machine learning are increasingly incorporated into clinical
practice and computer systems today aid the clinician in tasks that were long thought only pos-
sible for human experts [8]. Several machine learning algorithms have been previously used
for the detection of heart valve diseases. These range from fuzzy logic [9–11], hidden markov
models [12–14] and support vector machines [15–25] to artificial neural networks [25–35],
and in recent years convolutional neural networks [36–43] and recurrent neural networks [43,
44]. Some studies combined multiple classifiers to an ensemble method to increase the accu-
racy of the system [24, 30, 35, 40, 45, 46]. The majority of the previous studies was based on
classification of heart sounds, but little effort has been made to use such methods for the analy-
sis of temporal patterns of blood flow rate downstream of the valve using an unsupervised
learning approach. Instead, most current frameworks use supervised learning algorithms that
require labeled reference datasets, which can be difficult and time-consuming to obtain. The
performance of such systems can suffer if the process of patient data acquisition differs from
that used for the reference data, e.g. the positioning of a handheld Doppler probe, and if physi-
ological and pathological features are insufficiently represented in the training data. In this
article, we propose the use of novelty detection algorithms to automatically detect heart valve
degradation based on blood flow measurements without the need for user feedback or external
reference datasets.
Materials and methods
Our method monitors the temporal evolution of valvular function to detect progressive valve
degradation. It uses training data and monitoring data that originates from the implanted
valve, acquired during specific phases. These phases are illustrated in Fig 1. When a BHV is
implanted, it is given some run-in time to allow for the body to adapt to the newly implanted
BHV and to reach a quasi-steady state of the functioning valve. After this, the characteristic
temporal patterns of blood flow rate downstream of the valve are recorded during a training
phase (e.g. with an implantable flow sensor) and are used to train a patient-specific baseline
model that resembles the dynamics of the healthy BHV. Other than in supervised learning
approaches, this model is tailored to the implant and no information on general heart valve
characteristics (e.g from an external heart valve reference database) is required. The training
phase is succeeded by a monitoring phase in which blood flow recordings are acquired and
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are compared to the baseline model to automatically detect adverse events in form of irregu-
lar flow patterns. First indications of valvular degradation may be observed in the flow pat-
terns well before the onset of clinical symptoms, giving more time and treatment options to
restore the normal physiology [47]. Fig 2 shows the workflow during the monitoring phase
from data acquisition to automated diagnostic tasks. First, blood flow data is gathered to
obtain the characteristic blood flow pattern behind the AV. This data, typically spanning
multiple cardiac cycles, is preprocessed to improve the signal quality and to bring it into a
format suitable for computer algorithms. The data is then computer-analyzed using methods
of machine learning, which yield diagnostic insight into the state of the AV. To take full
advantage of the proposed method, all steps in the measurement chain should be automated
as far as possible.
Data acquisition
To enable assessment of valvular function it is necessary to measure the flow characteristics
downstream of the AV. This flow data can be obtained through current diagnostic modalities,
such as Doppler echocardiography or flow-MRI. Preferably, the data is acquired using a flow
sensing implant, capable of in-situ flow measurement and transcutaneous data transmission.
The use of such technology allows for automation of the data acquisition step, facilitating the
recording of periodic measurements in a semi-continuous fashion over an extended period of
time [48]. The data acquisition methodology must be capable of resolving the temporal blood
flow rate profile with sufficient resolution to capture all important features of the characteristic
blood flow pattern.
Fig 1. The phases of automated BHV monitoring. After aortic valve replacement (AVR), the body is given some time to adapt
to the new valve. Then a physiological baseline model of the healthy BHV is trained. This model is used during the monitoring
phase to automatically detect valvular degradation which may show well before the onset of clinical symptoms.
https://doi.org/10.1371/journal.pone.0222983.g001
Fig 2. Workflow from data acquisition to automated diagnostics. The workflow includes all steps of data acquisition, data preprocessing, model prediction
and automated diagnostic insight.
https://doi.org/10.1371/journal.pone.0222983.g002
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Data preprocessing
A typical flow recording contains continuously acquired data from multiple subsequent heart-
beats. The preprocessing step condenses this data into a single cardiac cycle and performs fea-
ture scaling to maximize the performance of the machine learning model. This is done by
fitting a sinusoid to the data, which allows identifying the instantaneous phase in the cardiac
cycle from multiple heartbeats. Fig 3 shows all steps required for data preprocessing. The
recording contains the instantaneous flow rate over multiple subsequent cardiac cycles (Fig
3A). A sinusoid of the form A sin(2πft + ϕ) + b is fitted to this periodic signal using a Leven-
berg-Marquardt algorithm [49, 50] to obtain the phase ϕ and the frequency f of the signal’s
first harmonic (Fig 3B). While a sinusoidal curve fit is not a good approximation of the cardiac
flow rate profile, it proved to be a very robust method to determine phase and base frequency
of the signal and outperformed methods that rely on local features. The locations of the sinu-
soid’s extrema are then used to slice the data and to map the whole data onto a single cardiac
cycle (Fig 3C) by defining a new time variable τ as τ = t mod T, where T is the period of one
cardiac cycle. The data is subsequently scaled to have zero mean and unit variance by rescaling





where �X is the arithmetic mean of X and σ is the standard deviation. This scaling, also known
as standardization, brings all feature axes onto an equal scale which is a necessary precursor
for optimal performance of the support vector machine (SVM) that will be used (the SVM
algorithm is not scale-invariant [51]). A set of three representative features (Z1, Z2, Z3) was
defined to characterize the dynamic behavior of the postvalvular flow characteristics. These are
the phase in the cardiac cycle (Z1), the instantaneous flow rate (Z2) and the heart rate (Z3).
Model prediction
Flow measurements downstream of the healthy aortic valve are used to obtain a patient-spe-
cific physiological baseline. This data is recorded for the freshly implanted valve (after the
body has adapted to the surgery) yielding a statistical model of the fully-operational BHV.
After model training, all further measurements will be compared to this baseline model to
detect valvular pathology, i.e. behavior that deviates from this baseline. We hypothesize that
such a deviation can be automatically detected using a novelty detection algorithm, which is a
special type in the class of anomaly detection algorithms [52], and that such a deviation from
the baseline is indicative of a valvular pathology. We consider the detection of novelty suffi-
cient for the detection of heart valve degradation despite its indifference to the type of model
deviation because the evolution of valvular function over time is a unidirectional process, gov-
erned by progressive valve degradation. It is therefore sufficient to detect novelty, and not a
predefined pathology because any novelty (i.e. atypical behavior) can be regarded as indicative
of an underlying pathology. Obtaining a statistical model of typical behavior amounts to defin-
ing a separating hyperplane in the feature space that separates normal (physiological) states
from novel (pathological) states. This hyperplane constitutes a decision boundary that is used
to differentiate between normal and novel states, depending on which side of the decision
boundary a given sample falls. Fig 4 illustrates the principle of novelty detection in cardiac
blood flow patterns. The reference data (circles) is used to define the decision boundary that
separates regular from irregular states (dashed line). A new observation that falls inside the
decision boundary (red shaded region) is regarded regular, one that falls outside the decision
boundary (blue shaded region) is deemed irregular (novel). In this context, a novelty
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corresponds to a new observation that does not originate from the same statistical distribution
as the baseline model. Some of the reference data falls outside the decision boundary after
model training. This situation is encountered in the presence of noise in the training data. A
certain fraction of boundary violations must be permitted during model training to prevent
Fig 3. Steps of data preprocessing. A: temporal flow rate recording over multiple cardiac cycles. B: sinusoidal fit to
determine phase and frequency of signal’s first harmonic. C: phase average and data standardization.
https://doi.org/10.1371/journal.pone.0222983.g003
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overfitting. The result of baseline model compilation is evaluated with the corresponding
model training- and test score, i.e. the agreement between model and training data and inde-
pendent baseline data, respectively. It is computed by applying the baseline data to the trained
classifier and by evaluating the fraction of correct classifications. The use of one-class SVMs
has been successfully applied for novelty detection in datasets [53]. The one-class SVM has an
important distinction from conventional SVM formulations in that it constitutes an unsuper-
vised learning algorithm and hence does not rely on a labeled training dataset. As the name
suggests, the one-class SVM consists of a single class of normal states and no further classes
need to be explicitly defined during model training, in contrast to the classical SVM formula-
tion. This property allows us to generate self-calibrating and patient-specific models of the car-
diac flow characteristics that can offer a high sensitivity because the model does not need to
generalize to a broad patient base, but is uniquely tailored for each subject. Schölkopf et al.
[53] have formulated the mathematical description of the one-class SVM, which is briefly
reviewed here.
Considering a training dataset, given by training samples x1, . . ., xl, it is the training objec-
tive to define a hyperplane in a high-dimensional feature space that separates this data from
the origin with the largest possible margin. Finding a hyperplane that separates the data from
the origin in the feature space is a concept that is special to one-class classification and builds
on the principle that the origin is part of the outlier class, which allows deriving the optimal
hyperplane using classical two-class SVM methodologies. The hyperplane is parameterized by
a vector containing the feature weights ω and a bias term ρ. Maximizing the distance to the ori-
gin equates to minimizing the term kωk2. A set of slack variables ξi is introduced to prevent
overfitting by allowing a predetermined fraction of boundary violations (i.e. training samples
that fall onto the wrong side of the separating hyperplane after model training). This is con-
trolled by the hyperparameter ν which sets the maximum fraction of allowable boundary
Fig 4. Principle of novelty detection in cardiac flow patterns. Red shaded region: inliers, blue shaded region:
outliers, dashed line: decision boundary, circles: baseline data, crosses: new observation.
https://doi.org/10.1371/journal.pone.0222983.g004
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violations and the minimum fraction of support vectors. As SVMs rely on linearly separable
datasets, but real data is often highly nonlinear, the original data must be transformed into a
higher-dimensional space in which the data becomes linearly separable using a transformation











xi   r ð2Þ
subject to ðω � FðxiÞÞ � r   xi; xi � 0: ð3Þ
The constraints (ω � F(xi))� ρ − ξi and ξi� 0 ensure that the training samples lie on the cor-
rect side of the hyperplane. A decision function is defined that predicts whether a given input
sample should be regarded regular, or irregular and takes the form
f ðxÞ ¼ sgnðω � FðxÞ   rÞ: ð4Þ
The computational complexity due to transformation of the input data into the higher-dimen-
sional space can be greatly reduced using a kernel function of the form
kðx; yÞ ¼ ðFðxÞ � FðyÞÞ: ð5Þ
Using suitable kernels, computations in the higher-dimensional space can be performed with-
out actually transforming the data (“kernel-trick”) [54]. The optimization problem can be














ai ¼ 1; ð7Þ
which yields the decision function
f ðxÞ ¼ sgn
Xl
i¼1
aikðxi; xÞ   r
 !
: ð8Þ
The bias term ρ of the decision function can be computed as





We define a diagnostic index that is indicative of the severity of valvular malfunction. It quan-
tifies how well a given measurement agrees with the baseline model, where model agreement
equates lack of novelty. This model compliance index (MCI) is defined as the fraction of mea-
surement samples that lie within the decision boundary (inliers), compared to the total num-





This simple scalar can be monitored over time to reveal progressive valve degradation,
expressed as declining MCI. A perfect agreement between measurement and baseline model
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would yield an MCI equal to the model training score. Deviations from the physiological base-
line result in a larger fraction of samples falling outside the decision boundary and conse-
quently a reduced MCI. Monitoring the MCI over time can yield insight into the severity and
the progression rate of AV degradation.
In-vitro test case
Aortic regurgitation (AR) is a common heart valve disease in which the valve’s leaflets fail to
close completely during the diastolic phase [55]. This leads to a reflux of blood from the aorta
back into the ventricle. It can affect native valves and it is also a common failure mode for
BHVs. We chose this common valvular pathology to test the methodology introduced above
and to confirm that such a condition can be automatically detected. The scenario was imitated
in an in-vitro pulsatile flow loop capable of producing flow and pressure conditions that
resemble the human systemic circulation [56]. It features a test section that can host a BHV
and that allows attaching a flow sensor downstream of the valve at the location of the ascend-
ing aorta (Fig 5). The system was set to physiological flow and pressure conditions for a
human at rest (cardiac output 5 l/min, systolic to diastolic pressure 120/80 mmHg, heart rate
60 BPM). A magnetic flow sensor recorded the time-resolved instantaneous flow rate in the
ascending aorta and was used to acquire 10 measurements of 1000 samples each at a sample
rate of 60 Hz to obtain the physiological baseline [48]. The flow sensor was placed in proximity
of the valve, approximately two annulus diameters downstream of the BHV to resolve the com-
plex dynamics of the flow rate profile in the ascending aorta. The acquired data carried the
characteristic signature of the valve, including important fluid-dynamic landmarks, such as
peak-systolic flow, blood reflux associated with the dynamics of valve closure and any potential
leakage during diastole. Artificial AR was subsequently created by placing tube-shaped inserts
in the center of the valve to deliberately create AR of increasing severity by preventing full
valve closure during diastole (Fig 6). A similar approach has also been used by [57]. Three dif-
ferently sized inserts were used to reproduce cases of mild, moderate and severe AR, in com-
pliance with the American Heart Association guidelines [47]. The cross-sectional area of the
inserted tubes was 10.0 mm2, 31.4 mm2 and 99.4 mm2, respectively. All measurements were
Fig 5. Test section including model of the aortic root with BHV and a flow sensor at the ascending aorta. A pulsatile flow loop reproduces
physiological flow and pressure conditions in the aortic root. A BHV is mounted inside the aortic root and a downstream flow sensor records the
temporal flow rate in the ascending aorta. LV: left ventricle.
https://doi.org/10.1371/journal.pone.0222983.g005
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performed at a constant heart rate, which reduced the problem to two representative features,
Z1 and Z2 for this setting, because the feature Z3 (heart rate) becomes obsolete.
Results
The blue lines in Fig 7 indicate raw data as recorded by the flow sensor (A: baseline, B: mild
AR), expressed as analog-to-digital converter (ADC) value. A comparison of Fig 7A and 7B
illustrates that the changes in the characteristic patterns of flow rate can be subtle and easy to
miss for an inexperienced observer. A sinusoid was fitted to the data (green line in Fig 7) and
then sliced at the locations indicated by dashed lines. The slices were used to link and condense
the data that was subsequently scaled to standardized variables. These steps were repeated for
each of the baseline measurements. The preprocessed baseline measurements were then used
to train the SVM to be used for novelty detection. We used the one-class SVM implementation
as proposed by [53], contained in the scikit-learn package [58]. A Gaussian radial basis func-
tion (RBF) as given in Eq 11 was used as kernel function for the SVM
kðx; yÞ ¼ e  gkx  yk2 ; ð11Þ
where two hyperparameters control the shape of the resulting decision function. These are the
kernel coefficient of the RBF γ (which controls the amount of regularization) and the fraction
of allowable boundary violations ν. Fig 8 shows 12 classifiers that were trained using the base-
line data and different combinations of the model parameters γ and ν to illustrate their effect.
An algorithm that allows no or few boundary violations (small ν) is said to have a hard margin.
One that has more relaxed constraints on boundary violations has a soft margin. The kernel
coefficient γ controls the width of the RBF and thereby the radius of influence of each training
sample. A high γ limits the influence of each training sample to its close proximity and can
lead to an irregular and complex decision function. When γ is reduced, it acts as a regulariza-
tion term leading to a smoother decision function. The parameter ν is used to penalize bound-
ary violations. When ν is small, the training algorithm ensures that a large fraction of the
training samples reside within the inlier region. A relaxation of ν typically leads to a smaller
inlier region as more training samples are allowed to fall into the outlier region. It was our
training objective to accurately resolve the dynamics of the flow rate profile while keeping the
decision function smooth and avoiding overfitting. Models with high regularization (top row
in Fig 8) failed to represent the flow rate profile and its steep gradients, while those using a
high γ (bottom row) resulted in an irregular decision function that would not generalize well
to new data. Models with a hard margin showed a tendency to overfitting (left column), while
gaps appeared in the decision function (where samples would always be classified as outliers)
when ν was set too high (right column). The optimal set of model parameters was determined
Fig 6. Valve during diastole with inserts creating an artificial leak. A: no AR, B: mild AR, C: moderate AR, D: severe AR.
https://doi.org/10.1371/journal.pone.0222983.g006
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in a grid search in which various combinations of ν and γ were analyzed. The performance
metric for parameter optimization was the ability of the model to discern baseline data from
AR data, i.e the sensitivity of the MCI towards pathological flow. It was evaluated as the aver-
age difference between the MCI for AR and the baseline MCI. The highest sensitivity was
achieved for ν = 0.05, and it increased with γ. Little gains in sensitivity could be obtained
Fig 7. Sinusoidal fit to the measurement data. Blue line: raw data, green line: sinusoidal fit, dashed lines: slicing
locations. A: baseline measurement (no AR), B: mild AR.
https://doi.org/10.1371/journal.pone.0222983.g007
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beyond γ = 7. Instead, the resulting models became more irregular and showed signs of overfit-
ting, limiting their ability to generalize to new data. We tuned the model to allow for 5% train-
ing errors (ν = 0.05, model training score of 0.95) to account for noise in the baseline data,
while avoiding gaps in the decision function. The kernel coefficient of the RBF was set to γ = 7
for a good compromise between sensitivity and regularization (i.e. maintaining a smooth deci-
sion function). Fig 9 illustrates the resulting baseline model that was trained on the baseline
Fig 8. Effect of model hyperparameters on decision function. The shape of the decision function is influenced by the hyperparameters γ and ν.
https://doi.org/10.1371/journal.pone.0222983.g008
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data using ν = 0.05 and γ = 7. It reflects the flow characteristics of the fully-functioning valve,
including its natural variance.
For each of the three cases of AR, eight measurements with a length of 1000 samples each
(�16 cardiac cycles) were recorded with the downstream flow sensor. This data was subse-
quently preprocessed as outlined above and applied to the baseline SVM. The results of model
prediction were then used to compute the MCI. Fig 10 shows a recording for the mild AR case,
overlaid onto the baseline decision function plot. A larger fraction of the acquired samples fell
outside the inlier region (pale red) when compared to the baseline measurements and these
samples were thus flagged as novelty by the algorithm. This led to a decrease in MCI compared
to the baseline of 0.95. This process was repeated for each of the measurements and their statis-
tics are depicted in Fig 11 with bar plots of the MCI for the control (baseline) and each AR sce-
nario. The blue bars indicate the median MCI and the interquartile range (iqr) is shown as
error bars. All cases were significantly different, according to a one-sided Wilcoxon rank
sum test at a 1% significance level. The control measurements had a median MCI of 0.95
(iqr = 0.018), equal to the model training score. Successive introduction of artificial AR led to a
sharp drop in MCI. The median MCI for mild AR was 0.72 (iqr = 0.061), the median MCI of
moderate AR was 0.4 (iqr = 0.037) and that of the severe AR was 0.17 (iqr = 0.015) with little
agreement between measurement and baseline model.
Discussion
The high sensitivity of the MCI with respect to AR indicates that the novelty detection algo-
rithm is capable of identifying valvular degradation based on the flow rate recordings. Even
Fig 9. Baseline one-class SVM model. The baseline data was used to train the one-class SVM to obtain a statistical model of
physiological states. Red line: decision boundary, pale red region: inlier region, shades of blue: signed distance to the decision
boundary in the outlier region, green dots: baseline flow measurement.
https://doi.org/10.1371/journal.pone.0222983.g009
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mild AR led to a significant reduction in MCI from the baseline. Keeping the base frequency
of the pulsating piston pump constant for all scenarios allowed us to reduce the problem to
two features (Z1, Z2). This was done to reduce the complexity of the problem and to limit the
amount of data that needed to be acquired to obtain a representative physiological baseline.
However, an analogous approach may be used that includes all three features (Z1, Z2, Z3). The
study of three cases of AR yielded discrete results for the MCI, which can be understood as
intermediate stages of the gradual process of valvular degradation in the human body. Moni-
toring the MCI over time enables determination of the severity and the rate of valvular degra-
dation which may be used to guide further action. We limited the experimental test case to the
detection of AR, but the same approach may be used to detect valvular defects due to other
pathologies, such as aortic stenosis. Furthermore, we limited our discussion to the detection
of BHV malfunction, but the nature of this method (unsupervised, patient-specific) permits
applications in other scenarios where monitoring of physiological function is of interest.
Limitations
The in-vitro test setup, like any experimental model, is limited in its ability to accurately repli-
cate the fluid dynamics of the human cardiovascular system. We chose boundary conditions
that resemble physiological flow and pressure conditions for a human at rest. Being driven by
a computer-controlled piston pump, the setup did not express, however, any significant cycle-
to-cycle variability. This allowed us to tune the model for high sensitivity without generating
false positives. In real-life applications, some sensitivity may have to be traded for improved
robustness of the method to allow for such physiological variations. This includes the
Fig 10. Mild AR scenario measurement overlaid onto the baseline model. Red line: decision boundary, pale red region: inlier
region, shades of blue: outlier region, green dots: mild AR flow measurement.
https://doi.org/10.1371/journal.pone.0222983.g010
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optimization of the model parameters in a physiological setting that features the full complex-
ity of the human circulatory system. Nevertheless, the high sensitivity of the MCI with respect
to valvular degradation indicates that sufficient headroom exists for higher degrees of regulari-
zation while maintaining a critical level of sensitivity to automatically detect valvular complica-
tions. In-vivo experiments, e.g. in animal trials, are required to further test the proposed
methodology in an environment that is more representative of the human physiology. Com-
parison to classical diagnostic procedures studying the same subject could yield important
insights and may reveal potential for further optimization with respect to feature selection and
choice of model parameters. The use of an unsupervised learning algorithm, while providing
convincing advantages, also introduces some limitations when compared to supervised classi-
fication tasks. The novelty detection algorithm is indifferent to the source of novelty and does
not yield further insight into the type of underlying pathology. Thus, currently no direct link
exists between the MCI and predefined medical conditions, but it rather indicates the mere
presence and the evolution of a pathology. Therefore, it is meant as a monitoring tool that
allows for early detection of adverse valvular behavior that can be used to initiate further medi-
cal attention.
Future research
The limitations stated above suggest the direction of future research. This includes an animal
trial to determine model parameters appropriate for in-vivo applications, and to compare our
method with medical exams performed by a clinician. Of special interest will be the evolution
of the MCI for progressive valve degradation and its link to diagnostic findings from
Fig 11. Bar plots of MCI for different AR scenarios. The MCI was computed for the baseline and for each AR scenario. A sharp decrease
in MCI can be observed as artificial AR is introduced, confirming a high sensitivity of the proposed method.
https://doi.org/10.1371/journal.pone.0222983.g011
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echocardiography. Furthermore, the unsupervised monitoring system could be coupled with a
supervised classifier to argument a detected valvular degradation with a defined pathology,
such as aortic regurgitation or aortic stenosis. Such system could combine the advantages of
the unsupervised and the supervised learning approach with early detection of adverse events
through unsupervised anomaly detection and detailed disease diagnosis using a supervised
classifier when the pathology has sufficiently manifested. Further development targets the
coupling of the proposed methodology with implantable flow sensing devices to take full
advantage of automation both in data processing and data acquisition. Our discussion and
experimental investigations focused on the detection of heart valve diseases, but other patholo-
gies of the cardiovascular system offer themselves to a similar approach, such as the monitor-
ing of aortic aneurysms which may be grounds for future research.
Conclusion
Data-driven healthcare, being fueled by the rapid development of implantable sensor technolo-
gies creates a need for automated data processing that is scalable to the high data volume of a
large patient base. This automation must not be limited to preprocessing of data, but should
employ the power of machine intelligence to enable computer-assisted interpretation of
medical data. This is a prerequisite to enable long-term remote monitoring of patients
without an excessive increase in cost. The methodology used in this article may represent an
approach to tackle this challenge through the use of patient-specific models and unsupervised
learning algorithms that are scalable to a large user base and adaptable to various diagnostic
requirements.
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